Crimean-Congo hemorrhagic fever virus replicon particle vaccine is safe and elicits functional, non-neutralizing anti-nucleoprotein antibodies and T cell activation in rhesus macaques

Autor: Kleymann, Alyssa ^a, Karaaslan, Elif ^b, Scholte, Florine E.M. ^b, Sorvillo, Teresa E. ^{b, c}, Welch, Stephen R. ^b, Bergeron, Éric ^b, Elser, Stephanie ^a, Almanzar-Jordan, Melvyn R. ^a, Velazquez, Eric ^a, Genzer, Sarah C. ^a, Jean, Sherrie M. ^a, Spiropoulou, Christina F. ^b, Spengler, Jessica R. ^{b, ⁎}

Publikováno v: In Antiviral Research January 2025 233

High detection rates and genetic diversity of picobirnaviruses (PBVs) in pigs on St. Kitts Island: Identification of a porcine PBV strain closely related to simian and human PBVs

Autor: Joycelyn, Soh Jiaying, Ng, Agnes, Kleymann, Alyssa, Malik, Yashpal S., Kobayashi, Nobumichi, Ghosh, Souvik

Publikováno v: In Infection, Genetics and Evolution October 2020 84

Crimean-Congo hemorrhagic fever virus replicon particle vaccine is safe and elicits functional, non-neutralizing anti-nucleoprotein antibodies and T cell activation in rhesus macaques.

Autor: Kleymann A; Comparative Medicine Branch, Division of Scientific Resources, Centers for Disease Control and Prevention, Atlanta, GA, USA., Karaaslan E; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Scholte FEM; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Sorvillo TE; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA; Infectious Disease Department, CDC Foundation, Atlanta, GA, USA., Welch SR; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Bergeron É; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Elser S; Comparative Medicine Branch, Division of Scientific Resources, Centers for Disease Control and Prevention, Atlanta, GA, USA., Almanzar-Jordan MR; Comparative Medicine Branch, Division of Scientific Resources, Centers for Disease Control and Prevention, Atlanta, GA, USA., Velazquez E; Comparative Medicine Branch, Division of Scientific Resources, Centers for Disease Control and Prevention, Atlanta, GA, USA., Genzer SC; Comparative Medicine Branch, Division of Scientific Resources, Centers for Disease Control and Prevention, Atlanta, GA, USA., Jean SM; Comparative Medicine Branch, Division of Scientific Resources, Centers for Disease Control and Prevention, Atlanta, GA, USA., Spiropoulou CF; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Spengler JR; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: wsk7@cdc.gov.

Publikováno v: Antiviral research [Antiviral Res] 2024 Dec 01; Vol. 233, pp. 106045. Date of Electronic Publication: 2024 Dec 01.